Nadine Abi-Jaoudeh, M.D. FSIR CCRP
Dr. Abi-Jaoudeh is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and completed internship and residency at the University of Laval in Québec, Canada a fellowship in interventional radiology at the University of Virginia in Charlottesville, Va. She then joined National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of Clinical research of the department of Radiology and in late 2020 she became section chief of interventional radiology and most recently chair of the diversity and inclusion committee of radiology. She is principal investigator on multiple Phase I, II and III trials.
Her clinical interests include minimally invasive image guided interventions, including but not limited to, vascular and non-vascular oncological interventions. Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease as well as healthcare disparities in IR. Her goal is to grow a translational research program to improve UCI patient care and outcome
Dr Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology. Dr Abi-Jaoudeh is a member of the annual meeting committee of the SIR and was the chair of the SIR annual meeting in 2022. She is deputy editor of JVIR. She is the division chair of the clinical and registries committees of the SIR Foundation.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Philips Medical Systems IncTopic:imaging systemsDate added:03/12/2023Relationship end date:03/31/2023
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Teclison IncTopic:trialDate added:03/12/2023Relationship end date:12/31/2026
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Guerbet SATopic:trialDate added:03/12/2023Relationship end date:07/31/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Instylla HESTopic:trialDate added:03/12/2023Relationship end date:08/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BlackSwan IncTopic:trialDate added:03/12/2023Relationship end date:12/01/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Sirtex Medical Ltd (PI)Topic:trialDate added:03/12/2023Relationship end date:09/30/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Sirtex Medical Ltd (PI)Topic:various confidentialDate added:03/12/2023Relationship end date:02/28/2023
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Angiodynamics IncTopic:trialDate added:03/12/2023Relationship end date:11/30/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Medtronic IncTopic:various confidentialDate added:03/12/2023Relationship end date:03/31/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Pfizer IncTopic:various confidentialDate added:03/12/2023Relationship end date:10/31/2021